Menu
GeneBe

rs33938617

Variant summary

Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_057176.3(BSND):c.924G>A(p.Pro308=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.19 in 1,613,940 control chromosomes in the GnomAD database, including 31,307 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. P308P) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.18 ( 2695 hom., cov: 32)
Exomes 𝑓: 0.19 ( 28612 hom. )

Consequence

BSND
NM_057176.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: -3.67
Variant links:
Genes affected
BSND (HGNC:16512): (barttin CLCNK type accessory subunit beta) This gene encodes an essential beta subunit for CLC chloride channels. These heteromeric channels localize to basolateral membranes of renal tubules and of potassium-secreting epithelia of the inner ear. Mutations in this gene have been associated with Bartter syndrome with sensorineural deafness. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.95).
BP6
Variant 1-55008589-G-A is Benign according to our data. Variant chr1-55008589-G-A is described in ClinVar as [Benign]. Clinvar id is 46553.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-3.66 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.21 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
BSNDNM_057176.3 linkuse as main transcriptc.924G>A p.Pro308= synonymous_variant 4/4 ENST00000651561.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
BSNDENST00000651561.1 linkuse as main transcriptc.924G>A p.Pro308= synonymous_variant 4/4 NM_057176.3 P1

Frequencies

GnomAD3 genomes
AF:
0.179
AC:
27167
AN:
151960
Hom.:
2688
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.189
Gnomad AMI
AF:
0.296
Gnomad AMR
AF:
0.111
Gnomad ASJ
AF:
0.121
Gnomad EAS
AF:
0.000966
Gnomad SAS
AF:
0.0824
Gnomad FIN
AF:
0.162
Gnomad MID
AF:
0.111
Gnomad NFE
AF:
0.213
Gnomad OTH
AF:
0.156
GnomAD3 exomes
AF:
0.151
AC:
37999
AN:
250858
Hom.:
3609
AF XY:
0.152
AC XY:
20615
AN XY:
135624
show subpopulations
Gnomad AFR exome
AF:
0.192
Gnomad AMR exome
AF:
0.0822
Gnomad ASJ exome
AF:
0.111
Gnomad EAS exome
AF:
0.000598
Gnomad SAS exome
AF:
0.0794
Gnomad FIN exome
AF:
0.161
Gnomad NFE exome
AF:
0.212
Gnomad OTH exome
AF:
0.154
GnomAD4 exome
AF:
0.191
AC:
279283
AN:
1461862
Hom.:
28612
Cov.:
34
AF XY:
0.187
AC XY:
136184
AN XY:
727238
show subpopulations
Gnomad4 AFR exome
AF:
0.189
Gnomad4 AMR exome
AF:
0.0872
Gnomad4 ASJ exome
AF:
0.111
Gnomad4 EAS exome
AF:
0.000353
Gnomad4 SAS exome
AF:
0.0849
Gnomad4 FIN exome
AF:
0.169
Gnomad4 NFE exome
AF:
0.215
Gnomad4 OTH exome
AF:
0.173
GnomAD4 genome
AF:
0.179
AC:
27190
AN:
152078
Hom.:
2695
Cov.:
32
AF XY:
0.172
AC XY:
12750
AN XY:
74340
show subpopulations
Gnomad4 AFR
AF:
0.189
Gnomad4 AMR
AF:
0.111
Gnomad4 ASJ
AF:
0.121
Gnomad4 EAS
AF:
0.000968
Gnomad4 SAS
AF:
0.0821
Gnomad4 FIN
AF:
0.162
Gnomad4 NFE
AF:
0.213
Gnomad4 OTH
AF:
0.155
Alfa
AF:
0.177
Hom.:
1344
Bravo
AF:
0.176
Asia WGS
AF:
0.0360
AC:
126
AN:
3478
EpiCase
AF:
0.194
EpiControl
AF:
0.201

ClinVar

Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Benign, criteria provided, single submitterclinical testingGeneDxMay 09, 2017This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Benign, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineMay 07, 2012Pro308Pro in Exon 04 of BSND: This variant is not expected to have clinical sig nificance because it does not alter an amino acid residue, is not located within the splice consensus sequence, and has been identified in 20.5% (1438/7020) of European American chromosomes from a broad population by the NHLBI Exome Sequenc ing Project (http://evs.gs.washington.edu/EVS; dbSNP rs33938617). -
Bartter disease type 4A Benign:3
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 12, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Benign, criteria provided, single submitterclinical testingAthena DiagnosticsJun 02, 2017- -
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabJul 10, 2021- -
not provided Benign:1
Benign, criteria provided, single submitterclinical testingInvitaeFeb 01, 2024- -
Bartter syndrome Benign:1
Benign, no assertion criteria providedclinical testingNatera, Inc.Sep 16, 2020- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.95
Cadd
Benign
0.022
Dann
Benign
0.33

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs33938617; hg19: chr1-55474262; COSMIC: COSV64870714; API